BiotechTube

KarXT

Phase 3Recruiting
0 views this week 0 watching⚡ Active
Interest: 47/100
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Bipolar Disorder Type I With Mania or Mania With Mixed Features

Conditions

Bipolar Disorder Type I With Mania or Mania With Mixed Features

Trial Timeline

Jun 13, 2025 → Nov 2, 2026

NCT ID
NCT06951711

About KarXT

KarXT is a phase 3 stage product being developed by Bristol Myers Squibb for Bipolar Disorder Type I With Mania or Mania With Mixed Features. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06951711. Target conditions include Bipolar Disorder Type I With Mania or Mania With Mixed Features.

What happened to similar drugs?

20 of 20 similar drugs in Bipolar Disorder Type I With Mania or Mania With Mixed Features were approved

Approved (20) Terminated (3) Active (0)
✅Olanzapine + PlaceboEli LillyApproved
✅OlanzapineEli LillyApproved
✅OlanzapineEli LillyApproved
✅olanzapine + divalproex sodium + placeboEli LillyApproved
✅olanzapine + risperidoneEli LillyApproved
✅Topiramate + PlaceboEli LillyApproved
✅Olanzapine Fluoxetine Combination (OFC) + PlaceboEli LillyApproved

Hype Score Breakdown

Clinical
17
Activity
15
Company
15
Novelty
0
Community
0

Clinical Trials (5)

NCT IDPhaseStatus
NCT07288567Phase 3Recruiting
NCT07061288Phase 1Recruiting
NCT06951711Phase 3Recruiting
NCT06951698Phase 3Recruiting
NCT06882785Phase 3Recruiting

Competing Products

20 competing products in Bipolar Disorder Type I With Mania or Mania With Mixed Features

See all competitors
ProductCompanyStageHype Score
OlanzapineEli LillyPhase 3
32
Valproate + Lithium + Risperidone + OlanzapineEli LillyPhase 3
40
Olanzapine + PlaceboEli LillyApproved
43
FK949EAstellas PharmaPhase 3
40
FK949EAstellas PharmaPhase 3
40
FK949E + PlaceboAstellas PharmaPhase 2/3
38
Escitalopram + Bupropion XLLupin LimitedPhase 3
32
OlanzapineEli LillyApproved
43
Olanzapine Hydrochloride + Lithium CarbonateEli LillyPhase 3
40
olanzapine + lithium + valproate + carbamazepineEli LillyPhase 3
40
OlanzapineEli LillyApproved
43
OlanzapineEli LillyPhase 3
40
LY2979165 + PlaceboEli LillyPhase 1
29
olanzapine + divalproex sodium + placeboEli LillyApproved
43
olanzapine + risperidoneEli LillyApproved
43
LY2979165 + placeboEli LillyPhase 1
29
Topiramate + PlaceboEli LillyApproved
43
olanzapineEli LillyPhase 3
40
Olanzapine + PlaceboEli LillyPhase 3
40
Brenipatide + PlaceboEli LillyPhase 2
42